Although the multicentre trial of cryotherapy for retinopathy of prematurity showed that treatment of threshold disease (stage 3 acute ROP in zones 1 or 2, for eight cumulative or five contiguous clock hours, with plus disease) with cryotherapy results in a 50% decrease in unfavourable outcomes, a significant number of cases progress from threshold disease to stages 4 and 5 -that is, partial or total retinal detachment.' A previous study by Robinson and O'Keefe found an incidence of poor visual outcome (vision <6/60) in 56% of eyes reaching stage 3 disease and an incidence of total retinal detachment of 6 5%.2 This study examines the incidence of complications and the structural and visual outcomes of infants with grade 4 and 5 cicatricial retinopathy of prematurity.
Results-Thirty one eyes of 17 
Results
Thirty one eyes of 17 patients were included in the study. The mean gestation of the patients was 26-77 (range 24 to 30) weeks and the mean birth weight was 951-43 (range 600 to 1500) g. The mean postnatal age at the first eye examination was 12 (range 6 to 36) weeks or 39 weeks postmenstrual age (range 30 to 60) weeks (see Table 1 ). Transferred infants had a significantly lower mean gestational age than infants diagnosed in hospitals screened by the authors (p=0 04). The mean birth weight of transferred infants was also lower than that of the non-transferred infants but this was not statistically significant (p=0 6). The mean postnatal age at first eye examination was significantly greater in transferred versus nontransferred infants (p=0 009) and 80% (4/5) of the transferred infants were already stage 4 eyes, and the remaining five eyes had no perception of light (NPL). Five of these retinas were totally detached and four partially at the last funduscopy. Of the latter, two had a macular tractional band with a partial detachment, one had part of the posterior pole only attached, and one developed a rhegmatogenous detachment with a large hole postoperatively. Visual acuities attained in the cohort were 3/60 Snellen (or equivalent) or less in 29 eyes (93'5%); NPL in 13 eyes (42%), PL in six (19.4%), UCUSUM in eight (25-8%), and 3/60 in two (6-5%). Acuities of better than 3/60 to 6/18 were recorded in only two eyes (6'5%). Although the literature cites that encouraging anatomical results are obtainable by vitreoretinal surgery,7-'0 the visual outcome remains poor.7 8 11 12 Trese13 found that scleral buckling decreased the incidence of progression from stage 4 to stage 5 ROP by reducing the vitreous traction and allowing the retinal pigment epithelium to absorb subretinal fluid, thus facilitating retinal reattachment.
Greven and Tasman9 found that scleral buckling resulted in anatomical reattachment in 59% in a series of 22 eyes with traction retinal detachment secondary to ROP.
Machemer and deJuan'0 felt that scleral buckling should be tried first in stage 4B where tractional detachment involves the macula. For high detachment and where vitreous opacities were present they advocated closed vitrectomy. Zilis et a17 found that the preoperative configuration of the stage 5 retinal detachment was of prognostic importance with wide-wide funnel configurations having the best prognosis and narrow-narrow the worst.
In this study, both the anatomical results and the visual outcome of vitreoretinal surgery were disappointing. Seven of these cases had closed vitrectomy with lensectomy while two eyes had an encircling band only.
Microphthalmos was present in 48-4% of cases in this study. Previously, Pulido In the seven patients in this cohort, the glaucoma was due to pupillary block, resulting in angle closure glaucoma. There is forward movement of the lens-iris diaphragm, shallowing of the anterior chamber, and the formation of peripheral anterior synechiae and posterior synechiae in these chronically inflamed eyes.
Cataract was found in 54-8% (17 eyes) in this study. Glaucoma frequently co-exists with the lens opacities and lensectomy is one method of treating the glaucoma. 19 Removal of the lens was a very important aspect of management in our seven glaucoma cases. We successfully managed glaucoma in four eyes by lensectomy, in two eyes by trabeculectomy, and in one eye by PI.
In addition to glaucoma and lens opacities, the presence of chronic low grade inflammation also results in the formation of band keratopathy and corneal scarring. Eye rubbing in children with visual impairment due to advanced ROP also contributes to the corneal scarring.
Transfer of the baby from another hospital was associated with increasing age at initial eye examination (for transferred infants, the age of initial eye examination was obtained from information in the referral letter or notes accompanying the patient). Significantly more infants were first seen at or later than 8 weeks postnatal age (p=0009) in the transferred group. The mean postmenstrual age at initial eye examination for transferred infants was 46 weeks (range 36 to 60 weeks) and only two eyes were treatable at this stage with cryotherapy or diode laser (Table 1 ). The initial eye examination for the remaining infants took place at 6 weeks postnatal age during screening in maternity hospitals except for three infants who were seen later than recommended in the protocol.
The study shows the need for long term follow up in children who are blind from ROP.
It highlights the main complications which may occur, many of which need active management. We found that the results in vitreoretinal surgery on eyes with stage 4 and 5 ROP were disappointing and this highlights the need for better preventive measures or more effective management of the acute phase. The study illustrates the need for further training in screening in peripheral units or else a change in policy to transfer all infants with acute ROP to main centres before they achieve threshold disease.
The Cryo-ROP study found that zone 1 location of ROP carries an 8-24 times greater odds of proceeding to an unfavourable outcome than does location in zone 2. 20 We found that 57°/O (eight of 14) of eyes in this study which initially had pre-threshold or threshold ROP, had stage 3 disease in the posterior area of zone 2. Although we do not know the true incidence of treatment failure in posterior zone 2 for this sample, this finding supports the previous report that more posterior location of ROP is associated with a poorer outcome. We should revisit the concept of threshold disease, particularly in zones 1 and posterior zone 2, in terms of whether earlier treatment is required when ROP is located in these more posterior areas of the retina.
